http://orcid.org/0000-0002-0103-1621
References
- Lardieri A, McCulley L, Christopher Jones S, et al. Granulocyte colony-stimulating factors and aortitis: a rare adverse event. Am J Hematol. 2018;93:E333–E336.
- Benguerfi S, Thepault F, Lena H, et al. Spontaneous splenic rupture as a rare complication of G-CSF injection. BMJ Case Rep. 2018;2018:bcr-2017-222561.
- Shirasawa M, Nakahara Y, Niwa H, et al. Interstitial pneumonia following administration of pegfilgrastim during carboplatin and etoposide chemotherapy for small-cell lung cancer. Mol Clin Oncol. 2016;5:714–716.
- Yoshifuji H. Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy. Mod Rheumatol. 2019;29:287–293.
- Deipolyi AR, Czaplicki CD, Oklu R. Inflammatory and infectious aortic diseases. Cardiovasc Diagn Ther. 2018;8:S61–S70.
- Keser G, Aksu K. Diagnosis and differential diagnosis of large-vessel vasculitides. Rheumatol Int. 2019;39:169–185.
- Miller EB, Grosu R, Landau Z. Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF). Clin Rheumatol. 2016;35:1655–1657.
- Hiranuma K, Kusunoki S, Fujino K, et al. Drug-induced aortitis in a patient with ovarian cancer treated with bevacizumab combination therapy. Taiwan J Obstet Gynecol. 2018;57:750–752.
- Sato Y, Kaji S, Ueda H, et al. Thoracic aortitis and aortic dissection following pegfilgrastim administration. Eur J Cardiothorac Surg. 2017;52:993–994.
- Umeda M, Ikenaga J, Koga T, et al. Giant cell arteritis which developed after the administration of granulocyte-colony stimulating factor for cyclic neutropenia. Intern Med. 2016;55:2291–2294.
- Adiga GU, Elkadi D, Malik SK, et al. Abdominal aortitis after use of granulocyte colony-stimulating factor. Clin Drug Invest. 2009;29:821–825.
- Darie C, Boutalba S, Fichter P, et al. Aortitis after G-CSF injections. Rev Med Intern. 2004;25:225–229.
- Ramsay LB, Stany MP, Edison JD, et al. Gemcitabine-associated large vessel vasculitis presenting as fever of unknown origin. J Clin Rheumatol. 2010;16:181–182.
- Eyre TA, Gooding S, Patel I, et al. Gemcitabine-induced large vessel vasculitis demonstrated by PET CT: a rare, important side effect. Int J Hematol. 2014;99:798–800.
- Kurata A, Saito A, Hashimoto H, et al. Difference in immunohistochemical characteristics between Takayasu arteritis and giant cell arteritis: it may be better to distinguish them in the same age. Mod Rheumatol. 2019;1–23.
- Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, et al. Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis. Proc Natl Acad Sci USA. 2018;115:13045–13050.
- D'Souza A, Jaiyesimi I, Trainor L, et al. Granulocyte colony-stimulating factor administration: adverse events. Transfus Med Rev. 2008;22:280–290.